5P50AG025688-15 |
2019 |
$233451 |
5065 |
A Proteogenomic Approach to Understanding AD GWAS Results |
WINGO, THOMAS SPURGEON |
5P50AG025688-15 |
2019 |
$226832 |
5066 |
Defining the Properties of Pathogenic A-beta strains in AD |
WALKER, LARY C |
3P50AG025688-15S1 |
2019 |
$778844 |
8547 |
BIOMARKER CORE |
LAH, JAMES J |
5P50AG025688-15 |
2019 |
$308666 |
5059 |
Core A: Administrative Core |
LEVEY, ALLAN I |
5P50AG025688-15 |
2019 |
$464541 |
5060 |
Core B: Clinical Core |
LAH, JAMES J |
5P50AG025688-15 |
2019 |
$196565 |
5061 |
Core C: Data Management and Statistical Core |
STEENLAND, NELSON K |
5P50AG025688-15 |
2019 |
$226845 |
5062 |
D: Neuropathology Core |
GLASS, JONATHAN DAVID |
5P50AG025688-15 |
2019 |
$144094 |
5063 |
Core E: Outreach; Recruitment and Education Core |
HEPBURN, KEN W |
5P50AG025688-15 |
2019 |
$138908 |
5064 |
AD Biomarkers and Endothelial Dysfunction in Caucasians and African Americans |
HU, WILLIAM TZU-LUNG |
5P50AG025688-14 |
2018 |
$314586 |
5059 |
Core A: Administrative Core |
LEVEY, ALLAN I |
5P50AG025688-14 |
2018 |
$473449 |
5060 |
Core B: Clinical Core |
LAH, JAMES J |
5P50AG025688-14 |
2018 |
$200334 |
5061 |
Core C: Data Management and Statistical Core |
STEENLAND, NELSON K |
5P50AG025688-14 |
2018 |
$231193 |
5062 |
D: Neuropathology Core |
GLASS, JONATHAN DAVID |
5P50AG025688-14 |
2018 |
$146856 |
5063 |
Core E: Outreach, Recruitment and Education Core |
HEPBURN, KEN W |
5P50AG025688-14 |
2018 |
$141572 |
5064 |
AD Biomarkers and Endothelial Dysfunction in Caucasians and African Americans |
HU, WILLIAM TZU-LUNG |
5P50AG025688-14 |
2018 |
$238093 |
5065 |
A Proteogenomic Approach to Understanding AD GWAS Results |
WINGO, THOMAS SPURGEON |
5P50AG025688-14 |
2018 |
$234399 |
5066 |
Defining the Properties of Pathogenic A-beta strains in AD |
WALKER, LARY C |
3P50AG025688-14S1 |
2018 |
$121332 |
None |
Emory Alzheimers Disease Center |
LEVEY, ALLAN I |
3P50AG025688-13S1 |
2017 |
$174734 |
None |
Emory Alzheimers Disease Center |
LEVEY, ALLAN I |
5P50AG025688-13 |
2017 |
$175157 |
5065 |
A Proteogenomic Approach to Understanding AD GWAS Results |
WINGO, THOMAS SPURGEON |
5P50AG025688-13 |
2017 |
$116535 |
5064 |
AD Biomarkers and Endothelial Dysfunction in Caucasians and African Americans |
HU, WILLIAM TZU-LUNG |
5P50AG025688-13 |
2017 |
$258952 |
5059 |
Core A: Administrative Core |
LEVEY, ALLAN I |
5P50AG025688-13 |
2017 |
$393325 |
5060 |
Core B: Clinical Core |
LAH, JAMES J |
5P50AG025688-13 |
2017 |
$164906 |
5061 |
Core C: Data Management and Statistical Core |
STEENLAND, NELSON K |
5P50AG025688-13 |
2017 |
$124163 |
5063 |
Core E: Outreach, Recruitment and Education Core |
HEPBURN, KEN W |
5P50AG025688-13 |
2017 |
$281764 |
5485 |
Core F - Minority Engagement Core |
PARKER, MONICA WILLIS |
5P50AG025688-13 |
2017 |
$195222 |
5062 |
D: Neuropathology Core |
GLASS, JONATHAN DAVID |
5P50AG025688-13 |
2017 |
$194983 |
5066 |
Defining the Properties of Pathogenic A-beta strains in AD |
WALKER, LARY C |
5P50AG025688-12 |
2016 |
$118256 |
5063 |
CORE E: OUTREACH, RECRUITMENT AND EDUCATION CORE |
HEPBURN, KEN W |
3P50AG025688-12S2 |
2016 |
$268365 |
5485 |
CORE F - MINORITY ENGAGEMENT CORE |
PARKER, MONICA WILLIS |
5P50AG025688-12 |
2016 |
$185935 |
5062 |
D: NEUROPATHOLOGY CORE |
GLASS, JONATHAN DAVID |
5P50AG025688-12 |
2016 |
$184769 |
5066 |
DEFINING THE PROPERTIES OF PATHOGENIC A-BETA STRAINS IN AD |
WALKER, LARY C |
5P50AG025688-12 |
2016 |
$1547625 |
None |
EMORY ALZHEIMER'S DISEASE CENTER |
LEVEY, ALLAN I |
3P50AG025688-12S3 |
2016 |
$90536 |
None |
EMORY ALZHEIMER'S DISEASE CENTER |
LEVEY, ALLAN I |
3P50AG025688-12S2 |
2016 |
$268365 |
None |
EMORY ALZHEIMER'S DISEASE RESEARCH CENTER |
LEVEY, ALLAN I |
5P50AG025688-12 |
2016 |
$170008 |
5065 |
A PROTEOGENOMIC APPROACH TO UNDERSTANDING AD GWAS RESULTS |
WINGO, THOMAS SPURGEON |
5P50AG025688-12 |
2016 |
$110994 |
5064 |
AD BIOMARKERS AND ENDOTHELIAL DYSFUNCTION IN CAUCASIANS AND AFRICAN AMERICANS |
HU, WILLIAM TZU-LUNG |
5P50AG025688-12 |
2016 |
$246633 |
5059 |
CORE A: ADMINISTRATIVE CORE |
LEVEY, ALLAN I |
5P50AG025688-12 |
2016 |
$373969 |
5060 |
CORE B: CLINICAL CORE |
LAH, JAMES J |
5P50AG025688-12 |
2016 |
$157061 |
5061 |
CORE C: DATA MANAGEMENT AND STATISTICAL CORE |
STEENLAND, NELSON K |
2P50AG025688-11 |
2015 |
$168338 |
5065 |
A PROTEOGENOMIC APPROACH TO UNDERSTANDING AD GWAS RESULTS |
WINGO, THOMAS SPURGEON |
2P50AG025688-11 |
2015 |
$110994 |
5064 |
AD BIOMARKERS AND ENDOTHELIAL DYSFUNCTION IN CAUCASIANS AND AFRICAN AMERICANS |
HU, WILLIAM TZU-LUNG |
2P50AG025688-11 |
2015 |
$201534 |
5066 |
DEFINING THE PROPERTIES OF PATHOGENIC A-BETA STRAINS IN AD |
WALKER, LARY C |
2P50AG025688-11 |
2015 |
$1563031 |
None |
EMORY ALZHEIMER'S DISEASE CENTER |
LEVEY, ALLAN I |
5P50AG025688-10 |
2014 |
$181998 |
6943 |
COMPARISON OF IMPLICIT AND EXPLICIT COGNITIVE REHABILITATION OF MEMORY IN PATIENT |
HAMPSTEAD, BENJAMIN MICHAEL |
5P50AG025688-10 |
2014 |
$136552 |
6938 |
DATA MANAGEMENT AND STATISTICS CORE |
STEENLAND, NELSON K |
5P50AG025688-10 |
2014 |
$113817 |
6941 |
EDUCATION AND INFORMATION CORE |
HEPBURN, KEN W |
5P50AG025688-10 |
2014 |
$1499974 |
None |
EMORY ALZHEIMER'S DISEASE CENTER |
LEVEY, ALLAN I |
5P50AG025688-10 |
2014 |
$133045 |
6939 |
NEUROPATHOLOGY CORE |
GLASS, JONATHAN DAVID |
5P50AG025688-10 |
2014 |
$190801 |
6946 |
NOREPINEPHRINE-TrkB INTERATIONS IN Alzheimer's DISEASE |
WEINSHENKER, DAVID |
5P50AG025688-10 |
2014 |
$165560 |
6945 |
ROLE OF MIRNAS IN AD PATHOGENESIS |
JIN, PENG |
5P50AG025688-10 |
2014 |
$216447 |
6936 |
ADMINISTRATIVE CORE |
LEVEY, ALLAN I |
5P50AG025688-10 |
2014 |
$361754 |
6937 |
CLINICAL CORE |
LAH, JAMES J |
5P50AG025688-09 |
2013 |
$233323 |
6936 |
ADMINISTRATIVE CORE |
LEVEY, ALLAN I |
5P50AG025688-09 |
2013 |
$383148 |
6937 |
CLINICAL CORE |
LAH, JAMES J |
5P50AG025688-09 |
2013 |
$191837 |
6943 |
COMPARISON OF IMPLICIT AND EXPLICIT COGNITIVE REHABILITATION OF MEMORY IN PATIENT |
HAMPSTEAD, BENJAMIN MICHAEL |
5P50AG025688-09 |
2013 |
$145017 |
6938 |
DATA MANAGEMENT AND STATISTICS CORE |
STEENLAND, NELSON K |
5P50AG025688-09 |
2013 |
$120191 |
6941 |
EDUCATION AND INFORMATION CORE |
HEPBURN, KEN W |
5P50AG025688-09 |
2013 |
$141318 |
6939 |
NEUROPATHOLOGY CORE |
GLASS, JONATHAN DAVID |
5P50AG025688-09 |
2013 |
$201117 |
6946 |
NOREPINEPHRINE-TrkB INTERATIONS IN Alzheimer's DISEASE |
WEINSHENKER, DAVID |
5P50AG025688-09 |
2013 |
$174722 |
6945 |
ROLE OF MIRNAS IN AD PATHOGENESIS |
JIN, PENG |
5P50AG025688-08 |
2012 |
$181997 |
6943 |
COMPARISON OF IMPLICIT AND EXPLICIT COGNITIVE REHABILITATION OF MEMORY IN PATIENT |
HAMPSTEAD, BENJAMIN MICHAEL |
5P50AG025688-08 |
2012 |
$138628 |
6938 |
DATA MANAGEMENT AND STATISTICS CORE |
STEENLAND, NELSON K |
5P50AG025688-08 |
2012 |
$114232 |
6941 |
EDUCATION AND INFORMATION CORE |
HEPBURN, KEN W |
5P50AG025688-08 |
2012 |
$135118 |
6939 |
NEUROPATHOLOGY CORE |
GLASS, JONATHAN DAVID |
5P50AG025688-08 |
2012 |
$190802 |
6946 |
NOREPINEPHRINE-TrkB INTERATIONS IN Alzheimer's DISEASE |
WEINSHENKER, DAVID |
5P50AG025688-08 |
2012 |
$165974 |
6945 |
ROLE OF MIRNAS IN AD PATHOGENESIS |
JIN, PENG |
5P50AG025688-08 |
2012 |
$226403 |
6936 |
ADMINISTRATIVE CORE |
LEVEY, ALLAN I |
5P50AG025688-08 |
2012 |
$365276 |
6937 |
CLINICAL CORE |
LAH, JAMES J |
5P50AG025688-07 |
2011 |
$1528074 |
None |
EMORY ALZHEIMER'S DISEASE CENTER |
LEVEY, ALLAN I |
2P50AG025688-06 |
2010 |
$1550000 |
None |
EMORY ALZHEIMER'S DISEASE CENTER |
LEVEY, ALLAN I |
5P50AG025688-05 |
2009 |
$246275 |
3 |
ANALYSIS OF PROTEOMIC PATTERNS IN NEURODEGENERATION |
PENG, JUNMIN |
5P50AG025688-05 |
2009 |
$171132 |
9002 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
STEENLAND, NELSON K |
5P50AG025688-05 |
2009 |
$482131 |
9001 |
CLINICAL CORE |
BLIWISE, DONALD L. |
5P50AG025688-05 |
2009 |
$223454 |
2 |
CROSSED GENETIC RISK OF ALZHEIMER AND PARKINSON DISEASE |
LEVEY, ALLAN I |
5P50AG025688-05 |
2009 |
$140624 |
9004 |
EDUCATION AND INFORMATION TRANSFER CORE |
CLARK, PATRICIA C |
5P50AG025688-05 |
2009 |
$203277 |
9003 |
NEUROPATHOLOGY CORE |
GEARING, MARLA |
5P50AG025688-05 |
2009 |
$231848 |
1 |
SENSITIVE MEMORY TESTS FOR DIFFERENTIATING MCI SUBGROUPS |
ZOLA, STUART |
5P50AG025688-04 |
2008 |
$514131 |
9001 |
CLINICAL CORE |
BLIWISE, DONALD L. |
5P50AG025688-04 |
2008 |
$270863 |
2 |
CROSSED GENETIC RISK OF ALZHEIMER AND PARKINSON DISEASE |
LEVEY, ALLAN I |
5P50AG025688-04 |
2008 |
$149980 |
9004 |
EDUCATION AND INFORMATION TRANSFER CORE |
CLARK, PATRICIA C |
5P50AG025688-04 |
2008 |
$216847 |
9003 |
NEUROPATHOLOGY CORE |
GEARING, MARLA |
5P50AG025688-04 |
2008 |
$247239 |
1 |
SENSITIVE MEMORY TESTS FOR DIFFERENTIATING MCI SUBGROUPS |
ZOLA, STUART |
5P50AG025688-04 |
2008 |
$262618 |
3 |
ANALYSIS OF PROTEOMIC PATTERNS IN NEURODEGENERATION |
PENG, JUNMIN |
5P50AG025688-04 |
2008 |
$183447 |
9002 |
BIOSTATISTICS AND DATA MANAGEMENT CORE |
STEENLAND, NELSON K |